United Stateshea

US employers added 115,000 jobs in April, marking the first back-to-back advance in nearly a year, and the unemployment rate remained unchanged at 4.3%. Bloomberg's Michael McKee has our first read on the report.

Kenvue (NYSE:KVUE) reported a strong start to the 2026 fiscal year, characterized by significant bottom-line growth and a marked improvement in operational efficiency.

Claritev (NYSE:CTEV) reported modest top-line growth for the first quarter of 2026, as the company continues to scale its data and insights platform aimed at healthcare affordability.

Dr. Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, talks about how the White House is making prescription drugs more affordable, fighting fraud in healthcare, and the future of Medicare. He speaks to Bloomberg Television at the Milken Global Conference.

Oscar Health (NYSE:OSCR) delivered a record-breaking first quarter for 2026, posting a surge in net income and membership that indicates its "reset" strategy has taken firm root.

CVS Health (NYSE:CVS) delivered a strong start to fiscal 2026, surpassing the $100 billion quarterly revenue threshold as its diversified healthcare services model captured increased demand across pharmacy and insurance channels.

Novo Nordisk said this year's declines won't be as bad as initially expected thanks to the new Wegovy pill, which helped fuel sales in the first quarter. For the year, the worst drop for both profit and sales will be 12%, compared with 13% earlier. Bloomberg's Sanne Wass reports from Copenhagen.

Pfizer Inc. Chief Executive Officer Albert Bourla says President Donald Trump's nominee to lead the Centers for Disease Control and Prevention is a good choice. Bourla says Erica Schwartz is a "very credible scientist." Bourla also talks about earnings, their drug pipeline and doing business in China. He speaks to Bloomberg's David Westin.

Pediatrix Medical Group (NYSE:MD) reported first-quarter earnings that beat Wall Street estimates on both the top and bottom lines, as favorable reimbursement shifts helped the physician services leader overcome a softer volume environment.

National Healthcare Properties (NASDAQ:NHPAP) has entered into an agreement to sell a portfolio of 86 outpatient medical facilities for approximately $528 million.